X 4 Pharmaceuticals Inc (XFOR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der X 4 Pharmaceuticals Inc-Aktie (XFOR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.21% 1.566	1.744	0.90	1.434	0.56
Cost Of Revenue	7.67% 0.351	0.326	4.716	0.302	0.227
Gross Profit	14.32% 1.215	1.418	-3.816	1.132	0.333
Operating Expenses	3.88% 28.72	27.65	5.627	36.85	34.83
Benefits Costs and Expenses	14.44% 31.41	27.45	0.584	41.00	37.24
Costs And Expenses	14.44% 31.41	27.45	0.584	40.26	37.24
Operating Income/Loss	4.87% -27.51	-26.23	-9.443	-35.72	-34.50
Nonoperating Income/Loss	542.42% -2.336	0.528	9.759	-3.848	-2.181
Income/Loss From Continuing Operations Before Tax	16.11% -29.84	-25.70	0.316	-39.56	-36.68
Income Tax Expense/Benefit	181.08% -0.03	0.037	0.034	0.258	0.015
Income/Loss From Continuing Operations After Tax	15.83% -29.82	-25.74	0.282	-39.82	-36.70
Net Income/Loss	15.83% -29.82	-25.74	0.282	-39.82	-36.70
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	483.74% 43.27	7.413	6.84	0.6282	200.87
Diluted Average Shares	483.74% 43.27	7.413	6.8691	0.451	200.87
Basic Earnings Per Share	80.12% -0.69	-3.47	0.04	-0.20	-0.18
Diluted Earnings Per Share	80.12% -0.69	-3.47	0.04	-0.20	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%